Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 247

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience

Wenke, Klaus, Meiser, Bruno, Thiery, Joachim, Nagel, Dorothea, von Scheidt, Wolfgang, Krobot, Karl, Steinbeck, Gerhard, Seidel, Dietrich, Reichart, Bruno · 2003 · Circulation

Abstract

Background— Randomized clinical trials have demonstrated that the use of statins in heart transplant patients lowers cholesterol levels and significantly reduces mortality and the development of transplant vasculopathy. The aim of the present study was to test these effects and the safety of statin therapy over an 8-year period. Methods and Results— In 1991, a prospective, randomized, unmasked study was initiated to compare the efficacy of simvastatin, started on the fourth postoperative day (n=35), with that of dietary therapy alone (n=37). Because of significantly improved survival and a lower incidence of transplant vasculopathy, most patients in both groups received statins as open-label prescriptions after 4 years. After 8 years, the Kaplan-Meier survival rate was 88.6% in the simvastatin group versus 59.5% in the control group ( P <0.006 by log rank; hazard ratio, 0.24; 95% CI, 0.08 to 0.71). Deaths in the simvastatin and control groups were due to transplant vasculopathy (1 versus 4; P <0.2), severe transplant rejection (1 versus 5; P <0.1), malignancies (0 versus 3; P <0.1), and other causes (2 versus 3; P <0.7). The incidence of transplant vasculopathy confirmed by angiography was 24.4% in the simvastatin group versus 54.7% in the control group ( P <0.02 by log rank). There was no difference in organ function between the 2 groups. No severe adverse effects of the therapy were observed up to the end of the 8-year observation period. Conclusions— Simvastatin therapy initiated early after heart transplantation leads to significantly better 8-year survival rates and a significantly lower incidence of transplant vasculopathy without impairment of organ function or severe adverse effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000043241.32523.ee

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 247

Metadata

Authors
Wenke, K., Meiser, B., Thiery, J., Nagel, D., von Scheidt, W., Krobot, K., Steinbeck, G., Seidel, D., & Reichart, B.
Venue
Circulation
Published
2003-01-07
Volume
107
Issue
1
Pages
93-97
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2062661553
Cited by
247
References
5
FWCI
20.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience. https://app.cochat.ai/papers/10.1161/01.cir.0000043241.32523.ee
The paper
Wenke, K., Meiser, B., Thiery, J., Nagel, D., von Scheidt, W., Krobot, K., Steinbeck, G., Seidel, D., & Reichart, B. (2003). Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience. Circulation. https://doi.org/10.1161/01.cir.0000043241.32523.ee

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.